The Bill & Melinda Gates Foundation today announced its largest annual budget to date as it works toward a healthier, more prosperous world for all.
Its board of trustees formally approved the foundation’s $8.6 billion 2024 budget on January 13, 2024. The new budget represents an increase of 4% over 2023.
At the foundation’s “The Future of Health” event at the World Economic Forum Annual Meeting, Bill Gates will showcase several health innovations the foundation has funded and its partners have been developing.
Gates Foundation $8.6 Billion Budget to Save and Improve Lives in 2024
1 Billion Novel Polio Vaccinations Administered
The Global Polio Eradication Initiative (GPEI) recently launched a Make Polio History campaign to rally supporters of polio eradication. This effort included the novel oral polio type 2 (nOPV2) vaccine, which was launched in response to poliovirus type 2 outbreaks,
Over the past three years, approximately 1 billion nOPV2 doses have been administered in more than 35 countries worldwide, says the GPEI.
Houston's Flu and RSV Season Fizzles Out
As the world looks forward to a healthy 2024, various health agencies recently reported signs of changing influenza and respiratory syncytial virus (RSV) detections.
From a global perspective, the World Health Organization (WHO) Influenza Update N° 462 confirmed the influenza season increased in the temperate Northern Hemisphere,
Decrease in Head and Neck Cancer Incidence Seen During Pandemic
Localized cancer incidence decreased the most among men, Hispanic patients, individuals with larynx cancer
Vegetarian Diet Tied to Lower COVID-19 Incidence
However, no association seen for COVID-19 severity or duration
Vegetarian Diet Tied to Lower COVID-19 Incidence
However, no association seen for COVID-19 severity or duration
Updated Immunization Schedule Presented for Adults for 2024
Changes include recommendation for all adults to receive dose of new COVID-19 vaccine and RSV vaccination
Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events
Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease
Updated Immunization Schedule Presented for Adults for 2024
Changes include recommendation for all adults to receive dose of new COVID-19 vaccine and RSV vaccination
Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events
Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease